Position in CADL
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$0
-$61,013 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
9 quarters on record
Common Shares in CADL Over Time
Shares Held
Position Value (USD)
Derivatives in CADL
reported options exposure · as of Mar 31, 2026CallValue
$742,350
CallShares
151,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026JANE STREET GROUP, LLC holds $1,255,284,514 across 317 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
1,757,672 | $130,524,721 | |
| 2 | RPRX |
Royalty Pharma plc
|
2,400,382 | $115,146,324 | |
| 3 | TGTX |
Tg Therapeutics, Inc.
|
2,041,669 | $67,824,242 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
122,946 | $54,900,305 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
831,707 | $53,753,223 | |
| 6 | EXEL |
Exelixis, Inc.
|
1,087,030 | $46,622,715 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
223,615 | $42,274,415 | |
| 8 | BNTX |
BioNTech SE
|
336,757 | $29,930,962 |
All Filings in CADL
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $742,350 | 151,500 | Call | Defined | 2026-05-12 | |
| 2025-12-31 | $748,060 | 132,400 | Call | Defined | 2026-02-12 | |
| 2025-12-31 | $61,013 | 10,799 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $563,040 | 110,400 | Call | Defined | 2025-11-14 | |
| 2025-06-30 | $740,278 | 146,300 | Call | Defined | 2025-08-14 | |
| 2025-03-31 | $316,965 | 56,100 | Call | Defined | 2025-05-19 | |
| 2025-03-31 | $191,535 | 33,900 | Put | Defined | 2025-05-19 | |
| 2024-12-31 | $262,136 | 30,200 | Call | Defined | 2025-02-14 | |
| 2024-12-31 | $143,844 | 16,572 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $227,261 | 32,794 | Shares | Defined | 2024-11-15 | |
| 2024-09-30 | $277,200 | 40,000 | Put | Defined | 2024-11-15 | |
| 2024-06-30 | $74,152 | 11,960 | Shares | Defined | 2024-08-15 | |
| 2022-12-31 | $24,030 | 13,425 | Shares | Defined | 2023-02-15 | |
| No filing history on record for this holder in this stock. | ||||||